# Allgens Medical Science & Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allgens-medical-science-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.allgensmed.cn
- Total disclosed funding: $5.7M
- Latest round: Series B (Sep 26, 2017)
- Investors on record: 12

## About

Established in 2004 and based in Beijing, China, Allgens Medical Science & Technology Co., Ltd. is a medical technology company that focuses on regenerative medicine materials and implantable medical devices. In 2014, the company's artificial bone repair material has obtained the registration certificate of three types of medical device products in the fields of dentistry, plastic surgery and neurosurgery. In 2018, the company established a subsidiary called Shandong Aojing Biotechnology. In 2019, the company changed its name from Beijing Allgens Medical Technology Co., Ltd. to Allgens Medical Science & Technology Co., Ltd. In May 2021, the company was listed on the Shanghai Stock Exchange under the ticker ”688613“.

The company engages in the research and development of regenerative medicine materials and implantable medical devices. Its main products include filling bionic bone and nail channel filling rod. Biomimetic bone filling is used to repair bone defects such as fractures, deformity healing, and curettage of bone tumor lesions.

## Funding rounds

- Series B, Sep 26, 2017 — Cowin Capital, T-Capital, Qiaojing Capital, THG Ventures, Lake Ventures, Hanking Family Office, Beijing Hongfu Investment Management, Beijing High-precision Industry Development Fund
- Series A, Jul 28, 2015 — Baichuan Huida Investment
- Series A, Nov 18, 2013, $5.7M — BVCF Capital
- Series A, Jan 28, 2011 — Zhongguancun Venture Capital, T-Capital, Zhongguancun Development Venture

## Investors

- Zhongguancun Venture Capital (https://capitalatlas.ai/funds/zhongguancun-venture-capital) — Series A
- T-Capital — Series A, Series B
- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Series A
- BVCF Capital — Series A
- Baichuan Huida Investment (https://capitalatlas.ai/funds/baichuan-huida-investment) — Series A
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series B
- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Series B
- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Series B
- Lake Ventures — Series B
- Hanking Family Office — Series B
- Beijing Hongfu Investment Management — Series B
- Beijing High-precision Industry Development Fund — Series B
